10.1 Obstructive Ventilatory Defects: Asthma, COPD, Emphysema, Chronic Bronchitis, Bronchiectasis
Key Takeaways
- Airflow obstruction is physiologically defined by an FEV1/FVC ratio below the Lower Limit of Normal (LLN) or post-bronchodilator FEV1/FVC < 0.70 according to GOLD guidelines.
- GOLD grades post-bronchodilator FEV1 percent predicted as GOLD 1 at 80% or above, GOLD 2 at 50-79%, GOLD 3 at 30-49%, and GOLD 4 below 30%; the ATS/ERS 2005 impairment bands and the ATS/ERS 2022 z-score bands use different cut points and must not be mixed with GOLD.
- Expiratory flow-volume loop morphology in obstructive defects demonstrates classic concavity (scooping) during forced expiration due to dynamic small airway collapse.
- Distinguishing emphysema from chronic bronchitis relies on DLCO: emphysema exhibits reduced DLCO from loss of alveolar-capillary surface area, whereas chronic bronchitis demonstrates normal DLCO with preserved alveolar membrane structure.
- Air trapping is defined by an elevated Residual Volume (RV > 120% predicted or RV/TLC > 35-40%), while pulmonary hyperinflation is confirmed by an elevated Total Lung Capacity (TLC > 120% predicted).
Last updated: August 2026
10.1 Obstructive Ventilatory Defects: Asthma, COPD, Emphysema, Chronic Bronchitis, Bronchiectasis
Pattern recognition in pulmonary function test (PFT) interpretation requires a systematic, step-by-step approach. The primary objective when evaluating spirometry is to determine whether airflow is hindered during forced exhalation. Obstructive ventilatory defects are defined by pathologically reduced expiratory flow rates relative to lung volume, originating from airway narrowing, structural collapse, inflammation, or loss of parenchymal elastic recoil.
This section outlines the diagnostic algorithm for obstructive ventilatory defects, severity classification standards, flow-volume loop characteristics, the differentiation of air trapping versus hyperinflation, and clinical characteristics of asthma, emphysema, chronic bronchitis, and bronchiectasis essential for the NBRC CPFT examination.
Diagnostic Algorithm for Obstructive Ventilatory Defects
The fundamental physiological hallmark of an obstructive defect is a disproportionate reduction in the rate at which gas can be forcefully exhaled from the lungs relative to the total volume exhaled. Interpretation begins with evaluating forced spirometry parameters.
Step 1: Evaluating the $FEV_1/FVC$ Ratio
To establish the presence of an obstructive ventilatory defect, the technologist or interpreting physician must first examine the ratio of Forced Expiratory Volume in 1 second ($FEV_1$) to Forced Vital Capacity ($FVC$):
- Primary Standard (ATS/ERS Guidelines): An obstructive defect is present when the measured $FEV_1/FVC$ ratio falls below the Lower Limit of Normal (LLN), corresponding to a Z-score $< -1.645$ (below the 5th percentile of a healthy non-smoking reference population).
- GOLD Criteria (COPD Management): The Global Initiative for Chronic Obstructive Lung Disease (GOLD) utilizes a fixed post-bronchodilator threshold of $FEV_1/FVC < 0.70$ ($70%$) to define persistent airflow limitation in adults suspected of having COPD.
Clinical Pearl: Using the age-adjusted LLN prevents the overdiagnosis of obstruction in elderly patients (who naturally lose elastic recoil with age) and prevents underdiagnosis in young adults (who normally have baseline $FEV_1/FVC$ ratios $> 80%$).
Step 2: Severity Grading — Three Systems That Must Not Be Confused
Once an obstructive defect is established, severity is graded from $FEV_1$. Three published schemes exist, and mixing their cut points is one of the most common interpretation errors:
| Scheme | Basis | Bands |
|---|---|---|
| GOLD grades (COPD) | Post-bronchodilator $FEV_1$ % predicted | GOLD 1 $\ge 80%$; GOLD 2 $50$–$79%$; GOLD 3 $30$–$49%$; GOLD 4 $< 30%$ |
| ATS/ERS 2005 impairment | $FEV_1$ % predicted | Mild $> 70%$; Moderate $60$–$69%$; Moderately severe $50$–$59%$; Severe $35$–$49%$; Very severe $< 35%$ |
| ATS/ERS 2022 interpretive | $FEV_1$ z-score | Mild $-1.65$ to $-2.50$; Moderate $-2.51$ to $-4.00$; Severe $< -4.00$ |
The table below is the GOLD grading scheme, which is what most NBRC-style COPD items use:
\hline \text{GOLD Grade} & \text{Label} & FEV_1 \text{ (\% Predicted, post-BD)} & \text{Clinical Interpretation} \\ \hline \text{GOLD 1} & \text{Mild} & \ge 80\% & \text{Minimal exertional symptoms; early airway changes} \\ \text{GOLD 2} & \text{Moderate} & 50\%\text{ to }79\% & \text{Exertional dyspnea; noticeable exercise limitation} \\ \text{GOLD 3} & \text{Severe} & 30\%\text{ to }49\% & \text{Frequent exacerbations; dyspnea with daily activities} \\ \text{GOLD 4} & \text{Very Severe} & < 30\% & \text{Severe chronic dyspnea; resting hypoxemia or cor pulmonale} \\ \hline \end{array}$$ --- ## Expiratory Flow-Volume Loop Morphology Visual analysis of the graphic flow-volume curve provides immediate diagnostic clues regarding airflow limitation. In healthy individuals, the expiratory curve rises rapidly to a sharp Peak Expiratory Flow Rate ($PEFR$) and declines linearly toward zero flow at maximum exhalation ($FVC$). ### Characteristics of Obstructive Curves 1. **Concavity / "Scooping":** The hallmark of small airway obstruction is pronounced **concavity** (caving inward toward the volume axis) during the mid-to-late portion of the forced expiration curve. This represents reduced flow rates at lower lung volumes ($FEF_{25-75\%}$, $FEF_{50\%}$, and $FEF_{75\%}$). 2. **Reduced Peak Expiratory Flow:** In moderate to severe obstruction, $PEFR$ is markedly depressed, and the peak shifts to the right (toward higher volume). 3. **Prolonged Expiratory Time:** Dynamic airway collapse and high airway resistance prolong the forced expiratory time ($FET$), often requiring $> 6$ to $12$ seconds for the patient to reach a complete plateau. $$\begin{array}{cc} \hline \text{Flow-Volume Loop Parameter} & \text{Obstructive Pattern Manifestation} \\ \hline \text{Expiratory Curve Shape} & \text{Concave / "Scooped" appearance during mid-to-late expiration} \\ \text{Peak Expiratory Flow Rate (PEFR)} & \text{Reduced; delayed achievement of peak flow} \\ \text{Forced Expiratory Time (FET)} & \text{Significantly prolonged (> 6-12 seconds)} \\ \text{Expiratory Flow Rates } (FEF_{25-75\%}) & \text{Severe reduction out of proportion to total volume} \\ \hline \end{array}$$ --- ## Air Trapping versus Pulmonary Hyperinflation Airflow obstruction impairs gas emptying during exhalation, causing gas to become trapped behind narrowed or collapsed airways. Lung volume determinations via body plethysmography or gas dilution are required to distinguish **air trapping** from true **hyperinflation**. ### 1. Air Trapping Air trapping occurs when gas remains trapped in the lungs at the end of a maximal exhalation due to premature closure of small conducting airways. * **Diagnostic Criteria:** Elevated **Residual Volume ($RV > 120\%$ predicted)** or an elevated **$RV/TLC$ ratio ($> 35\%$ to $40\%$)**. * **Spirometric Effect:** Because gas is trapped in the $RV$ compartment, the usable Forced Vital Capacity ($FVC$) is reduced, even though Total Lung Capacity ($TLC$) remains within normal limits. ### 2. Pulmonary Hyperinflation Pulmonary hyperinflation refers to an absolute enlargement of the total thoracic gas volume at maximal inspiration. * **Diagnostic Criteria:** Elevated **Total Lung Capacity ($TLC > 120\%$ predicted)**. * **Physiological Mechanism:** Loss of pulmonary elastic recoil (as seen in emphysema) reduces the inward pull of the lungs, allowing the chest wall to expand outward and establish a larger equilibrium volume. $$\text{Air Trapping} = RV > 120\% \text{ predicted or } \frac{RV}{TLC} > 35\text{-}40\% \quad (TLC \text{ normal})$$ $$\text{Hyperinflation} = TLC > 120\% \text{ predicted} \quad (RV \text{ usually elevated as well})$$ --- ## Clinical Etiologies and Differential Diagnosis Obstructive ventilatory defects encompass several distinct clinical entities. The NBRC CPFT examination tests the technologist's ability to differentiate these conditions using spirometry, lung volumes, diffusing capacity ($DLCO$), and bronchodilator responsiveness. ### 1. Asthma * **Pathophysiology:** Chronic inflammatory disorder of the airways characterized by bronchial hyperresponsiveness, smooth muscle bronchospasm, mucosal edema, and mucous plugging. * **PFT Profile:** * Spirometry reveals an obstructive defect ($FEV_1/FVC < \text{LLN}$). * **High Reversibility:** Demonstrates significant improvement post-bronchodilator ($FEV_1$ or $FVC$ increases by $\ge 12\%$ and $\ge 200\text{ mL}$). Between acute exacerbations, spirometry may normalize completely. * **$DLCO$ Pattern:** $DLCO$ is **normal or characteristically elevated** ($> 100\%$ to $120\%$ predicted). Elevated $DLCO$ in asthma occurs due to increased pulmonary capillary blood volume driven by heightened negative intrathoracic pressures during inspiratory efforts. ### 2. Chronic Obstructive Pulmonary Disease (COPD): Emphysema vs. Chronic Bronchitis COPD represents a spectrum of progressive airflow limitation that is not fully reversible. It comprises two primary clinical phenotypes: #### A. Emphysema * **Pathophysiology:** Permanent enlargement of airspaces distal to terminal bronchioles accompanied by destruction of alveolar walls and capillary beds, without obvious fibrosis. Primary etiologies include cigarette smoking and $\alpha_1$-antitrypsin deficiency. * **PFT Profile:** * Spirometry shows fixed obstruction ($FEV_1/FVC < 0.70$). * Lung volumes reveal marked **hyperinflation ($TLC > 120\%$)** and severe **air trapping ($RV > 150\%$)**. * **$DLCO$ Pattern:** **Markedly REDUCED ($< \text{LLN}$)**. Alveolar septal destruction reduces the total surface area available for gas transfer and destroys the pulmonary capillary network. #### B. Chronic Bronchitis * **Pathophysiology:** Chronic inflammation of the tracheobronchial tree defined clinically by a chronic productive cough for at least 3 consecutive months in 2 consecutive years. Characterized by mucous gland hyperplasia, goblet cell metaplasia, and bronchial wall thickening. * **PFT Profile:** * Spirometry shows obstruction ($FEV_1/FVC < \text{LLN}$). * Lung volumes show moderate air trapping ($RV$ elevated, $TLC$ normal or slightly elevated). * **$DLCO$ Pattern:** **NORMAL ($> \text{LLN}$)**. Because alveolar capillary walls remain structurally intact, gas diffusing surface area is preserved. ### 3. Bronchiectasis * **Pathophysiology:** Irreversible structural dilation and destruction of major bronchi resulting from chronic, recurrent necrotizing infections (e.g., cystic fibrosis, primary ciliary dyskinesia). * **PFT Profile:** * Spirometry reveals moderate-to-severe airflow obstruction with disproportionately reduced mid-expiratory flow rates ($FEF_{25-75\%}$). * Copious sputum production can cause acute, transient fluctuations in flow rates. * $DLCO$ ranges from normal to mildly decreased depending on underlying parenchymal involvement. --- ## Diagnostic Matrix of Obstructive Disorders $$\begin{array}{lccccc} \hline \text{Clinical Condition} & FEV_1/FVC & TLC & RV & DLCO & \text{Bronchodilator Response} \\ \hline \text{Asthma} & < \text{LLN} & \text{Normal / High} & \text{Elevated (attacks)} & \text{Normal or } \uparrow & \text{Highly Reversible } (\ge 12\% \text{ and } 200\text{ mL}) \\ \text{Emphysema} & < 0.70 & \uparrow\uparrow (>120\%) & \uparrow\uparrow\uparrow (>150\%) & \mathbf{\downarrow\downarrow (< \text{LLN})} & \text{Fixed / Minimal Reversibility} \\ \text{Chronic Bronchitis} & < 0.70 & \text{Normal / Slightly } \uparrow & \uparrow (120-140\%) & \mathbf{\text{Normal } (\ge \text{LLN})} & \text{Partial or Minimal Reversibility} \\ \text{Bronchiectasis} & < \text{LLN} & \text{Normal / Slightly } \uparrow & \uparrow (120-140\%) & \text{Normal / Mildly } \downarrow & \text{Variable} \\ \hline \end{array}$$Test Your Knowledge
A 62-year-old male with a 40 pack-year smoking history undergoes pulmonary function testing. Spirometry demonstrates an FEV1/FVC ratio of 0.54 and a post-bronchodilator FEV1 of 42% predicted. Plethysmography confirms a TLC of 128% predicted and an RV of 165% predicted. Diffusing capacity (DLCO) is 45% predicted. Which clinical diagnosis is most consistent with these findings?
A
B
C
D
Test Your Knowledge
A patient has an FEV1/FVC ratio below the Lower Limit of Normal and a post-bronchodilator FEV1 of 64% predicted. How is the airflow limitation classified under the GOLD grading scheme?
A
B
C
D
Test Your Knowledge
What primary lung volume pattern distinguishes pulmonary hyperinflation from isolated air trapping?
A
B
C
D